Table 1.
Demographic and clinical variables for the participants’ groups.
| Variable | AD (n = 223) | Control (n = 57) |
|---|---|---|
| Age (years, median (IQR)) | 71 (67.5, 74) | 65 (62, 69) |
| Sex (female, n (%)) | 135 (60.54%) | 25 (43.86%) |
| CSF biomarkers | ||
| Aß42 levels (pg/mL, median (IQR)) | 600 (468.04, 702.1) | 1206.15 (996, 1472) |
| t-tau levels (pg/mL, median (IQR)) | 586 (414, 837) | 240 (182, 313) |
| p-tau levels (pg/mL, median (IQR)) | 92 (72.5, 131) | 42 (32, 56) |
| Ratio t-tau/Aß42 (median (IQR)) | 0.94 (0.68, 1.43) | 0.19 (0.14, 0.24) |
| Smoking history | ||
| No (n, %) | 145 (65.02%) | 34 (59.65%) |
| No (Ex-smoker), (n, %) | 45 (20.18%) | 10 (17.54%) |
| Yes (n, %) | 33 (14.8%) | 13 (22.81%) |
| Number of concomitant medications | 5 (3, 7) | 3 (2, 5) |
| Total cholesterol (mg/dL, median (IQR)) | 189 (165.25, 212) | 196 (170, 222) |
| HDL cholesterol (mg/dL, median (IQR)) | 55.5 (47, 66.25) | 55 (44, 67.6) |
| Lipid-modifying agents (n, %) | 123 (55.16%) | 28 (49.12%) |
| Antidiabetic drugs (n, %) | 36 (16.14%) | 11 (19.3%) |
| Systolic blood pressure (mmHg, median (IQR)) | 135 (124.58, 143.42) | 130 (118, 139) |
| Diastolic blood pressure (DBP) (mmHg, median (IQR)) | 75 (70, 81) | 78 (71, 82.5) |
| Hypertension (n, %) | 122 (54.71%) | 30 (52.63%) |
Aß42 = ß amyloid 42; CSF = cerebrospinal fluid; dL = deciliter; IQR = interquartile range; mg = milligrams; mL = milliliters; mmHg = millimeters of mercury; n = number of patients; pg = picograms; p-tau = phosphorylated tau; t-tau = total tau.